Target intelligence / Profile preview

Divalent metal transporter 1 (DMT1 (also known as NRAMP2 or DCT1))

Target
DMT1 (also known as NRAMP2 or DCT1)
Molecular classification
Transporter, Solute carrier family, Ion channel (specifically for divalent metal ions)
01

Overview

Divalent metal transporter 1 (DMT1), also known as natural resistance-associated macrophage protein 2 (NRAMP2) or solute carrier family 11 member 2 (SLC11A2), is a transmembrane protein responsible for the uptake of various divalent metal ions—most notably ferrous iron (\(\mathrm{Fe}^{2+}\)), but also manganese (\(\mathrm{Mn}^{2+}\)), zinc (\(\mathrm{Zn}^{2+}\)), copper (\(\mathrm{Cu}^{2+}\)), cadmium (\(\mathrm{Cd}^{2+}\)), and calcium (\(\mathrm{Ca}^{2+}\)). It is highly conserved across species from bacteria to humans. In mammals, it plays a critical role in dietary iron absorption in the intestine by transporting reduced \(\mathrm{Fe}^{2+}\) into enterocytes. Its broad substrate specificity means that it can mediate uptake not only of essential metals but also potentially toxic ones. Dysregulation or mutation in this transporter is associated with diseases involving abnormal metal homeostasis such as anemia or overload syndromes[3][4][5].

Other names
Natural resistance-associated macrophage protein 2 (NRAMP2)Divalent cation transporter 1 (DCT1)SLC11A2Metal ion transporter
02

Mechanism of action

H^+-coupled symport of divalent metal cations from the extracellular environment into cells

03

Biological functions

Metal ion transport across membranesMaintenance of cellular and systemic iron homeostasisAbsorption and distribution of essential metals such as iron, manganese, zinc, copper, cadmium
04

Disease associations

Iron-deficiency anemiaIron overload disorders (e.g., hemochromatosis)Manganese toxicity or deficiency
05

Safety considerations

Low selectivity can lead to absorption of toxic metals such as cadmium and lead
06

Interacting drugs

No specific drugs directly targeting DMT1 are currently approved; however, chelating agents and iron supplements can indirectly affect its function.
07

Biomarkers

Expression levels of SLC11A2/DMT1 in tissues may serve as biomarkers for disorders related to iron metabolism.

Beyond the preview

Go deeper on Divalent metal transporter 1 (DMT1 (also known as NRAMP2 or DCT1)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Divalent metal transporter 1 (DMT1 (also known as NRAMP2 or DCT1)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call